Streamlining Orthopedics ePA via NCPDP SCRIPT for Pharmacy-Related Authorizations

Navigating the complexities of prior authorizations in orthopedics often extends beyond medical procedures to crucial pharmacy benefits. Klivira specializes in automating orthopedics ePA via NCPDP SCRIPT, ensuring efficient processing for drug-related therapies.

For orthopedic practices, managing prior authorizations for advanced imaging, surgical procedures, and durable medical equipment is a significant operational challenge. Yet, a distinct segment of orthopedic care—pharmacy-covered medications and injectables—also demands stringent PA protocols, typically leveraging the NCPDP SCRIPT standard. This distinction is critical for revenue cycle directors and PA coordinators aiming for comprehensive authorization efficiency.

The Role of NCPDP SCRIPT in Orthopedic Pharmacy Authorizations

While many orthopedic prior authorizations are for medical benefits, certain drug-related therapies, such as viscosupplementation or specific orthobiologics, fall under pharmacy benefits. These require electronic prior authorization (ePA) submissions using the NCPDP SCRIPT standard. Klivira's platform is engineered to identify and process these distinct pharmacy PAs, ensuring compliance with payer requirements and adherence to the CMS ePA mandate.

Common Orthopedic Therapies Requiring ePA via NCPDP SCRIPT

Viscosupplementation (hyaluronic acid injections) for osteoarthritis, a high-volume PA category.
Specific corticosteroid injections when processed under pharmacy benefits for joint or soft tissue inflammation.
Certain orthobiologics, depending on payer coverage policies, if administered as a pharmacy benefit.
High-cost or restricted post-operative pain management medications that fall under pharmacy benefit management.

Integrating Orthopedic ePA Workflows with EMRs

Effective ePA for orthopedic pharmacy benefits relies on seamless data exchange. Klivira integrates with leading EMR systems via SMART on FHIR to extract relevant patient data—including diagnoses, medication history, and documentation of conservative-care trials. This automation reduces manual data entry for NCPDP SCRIPT submissions, minimizing errors and accelerating the authorization process for injectables and other pharmacy-covered treatments.

Key Documentation for Orthopedic Pharmacy ePA Submissions

Documentation of conservative-care trials, including duration and modalities, aligning with AAOS Clinical Practice Guidelines.
Imaging confirmation of pathology, such as advanced joint disease (e.g., Kellgren-Lawrence grade for OA) or structural spine pathology.
Clinical exam findings correlating with symptoms and the requested therapy.
Evidence of failed prior therapies or specific indications for the prescribed drug.

Navigating Payer Requirements for Orthopedic Pharmacy Benefits

Payers maintain distinct policies for pharmacy benefits related to orthopedic conditions, often with specific step therapy protocols or coverage criteria for injectables and biologics. Klivira's platform helps identify these varied requirements, routing NCPDP SCRIPT transactions to the correct payer channels and ensuring that submissions are complete and compliant with individual payer rules, reducing the likelihood of denials.

Klivira's Impact on Orthopedic Pharmacy PA Efficiency

By automating data extraction, facilitating accurate submission via NCPDP SCRIPT, and providing real-time status tracking, Klivira significantly reduces the administrative burden associated with pharmacy-related orthopedic PAs. This efficiency allows orthopedic practices to accelerate patient access to critical medications and injectables, improve PA approval rates, and reallocate valuable staff resources to patient care.

Frequently asked questions

How does NCPDP SCRIPT specifically apply to orthopedic care?

NCPDP SCRIPT is the standard for electronic prior authorization of pharmacy benefits. In orthopedics, this primarily applies to medications and injectables, such as viscosupplementation, certain corticosteroid injections, or specific orthobiologics, when these therapies are covered under a patient's pharmacy benefit plan rather than their medical benefit.

What specific orthopedic medications commonly require ePA via NCPDP SCRIPT?

Common orthopedic-related medications requiring ePA via NCPDP SCRIPT include viscosupplementation (hyaluronic acid) for osteoarthritis, certain corticosteroid injections if routed as a pharmacy benefit, and specific orthobiologics or high-cost pain medications that fall under pharmacy coverage policies.

How does Klivira handle the documentation requirements for orthopedic pharmacy PAs?

Klivira integrates with EMRs to automatically extract necessary documentation, such as conservative-care trial history, relevant imaging reports, and clinical findings. This ensures that all required information, often guided by AAOS Clinical Practice Guidelines, is included in the NCPDP SCRIPT submission, enhancing approval rates.

Can Klivira integrate with our EMR for orthopedic ePA submissions?

Yes, Klivira is designed for seamless integration with major EMR systems using standards like SMART on FHIR. This allows for automated data extraction, streamlined submission of NCPDP SCRIPT transactions, and efficient management of both medical and pharmacy prior authorizations directly from your existing clinical workflows.

What are common denial reasons for orthopedic pharmacy PAs?

Frequent denial reasons for orthopedic pharmacy PAs include insufficient documentation of conservative-care trials, lack of correlation between imaging findings and symptoms, the requested drug being considered non-covered per payer policy (e.g., some PRP injections), or failure to meet step therapy requirements for certain biologics or high-cost injectables.